These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 19331514)

  • 21. Common data elements for research on traumatic brain injury: pediatric considerations.
    Miller AC; Odenkirchen J; Duhaime AC; Hicks R
    J Neurotrauma; 2012 Mar; 29(4):634-8. PubMed ID: 22091862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Approach to Modeling, Therapy Evaluation, Drug Selection, and Biomarker Assessments for a Multicenter Pre-Clinical Drug Screening Consortium for Acute Therapies in Severe Traumatic Brain Injury: Operation Brain Trauma Therapy.
    Kochanek PM; Bramlett HM; Dixon CE; Shear DA; Dietrich WD; Schmid KE; Mondello S; Wang KK; Hayes RL; Povlishock JT; Tortella FC
    J Neurotrauma; 2016 Mar; 33(6):513-22. PubMed ID: 26439468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammation and neuroprotection in traumatic brain injury.
    Corps KN; Roth TL; McGavern DB
    JAMA Neurol; 2015 Mar; 72(3):355-62. PubMed ID: 25599342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cooling the injured brain: how does moderate hypothermia influence the pathophysiology of traumatic brain injury.
    Sahuquillo J; Vilalta A
    Curr Pharm Des; 2007; 13(22):2310-22. PubMed ID: 17692002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies.
    Loane DJ; Faden AI
    Trends Pharmacol Sci; 2010 Dec; 31(12):596-604. PubMed ID: 21035878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indomethacin: a review of its cerebral blood flow effects and potential use for controlling intracranial pressure in traumatic brain injury patients.
    Slavik RS; Rhoney DH
    Neurol Res; 1999 Jul; 21(5):491-9. PubMed ID: 10439431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertonic saline versus other intracranial pressure-lowering agents for people with acute traumatic brain injury.
    Chen H; Song Z; Dennis JA
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD010904. PubMed ID: 31886900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ethical and regulatory considerations in the design of traumatic brain injury clinical studies.
    Hicks R
    Handb Clin Neurol; 2015; 128():743-59. PubMed ID: 25701918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug therapies for stroke and traumatic brain injury often display U-shaped dose responses: occurrence, mechanisms, and clinical implications.
    Calabrese EJ
    Crit Rev Toxicol; 2008; 38(6):557-77. PubMed ID: 18615310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigational agents for treatment of traumatic brain injury.
    Xiong Y; Zhang Y; Mahmood A; Chopp M
    Expert Opin Investig Drugs; 2015 Jun; 24(6):743-60. PubMed ID: 25727893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury.
    McConeghy KW; Hatton J; Hughes L; Cook AM
    CNS Drugs; 2012 Jul; 26(7):613-36. PubMed ID: 22668124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacology of traumatic brain injury: where is the "golden bullet"?
    Beauchamp K; Mutlak H; Smith WR; Shohami E; Stahel PF
    Mol Med; 2008; 14(11-12):731-40. PubMed ID: 18769636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progesterone neuroprotection: The background of clinical trial failure.
    Schumacher M; Denier C; Oudinet JP; Adams D; Guennoun R
    J Steroid Biochem Mol Biol; 2016 Jun; 160():53-66. PubMed ID: 26598278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Path to the execution of explorative clinical researches in National Cerebral and Cardiovascular Center (NCVC)].
    Yamamoto H
    Yakugaku Zasshi; 2013; 133(2):209-12. PubMed ID: 23370515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Traumatic brain injury research priorities: the Conemaugh International Brain Injury Symposium.
    Zitnay GA; Zitnay KM; Povlishock JT; Hall ED; Marion DW; Trudel T; Zafonte RD; Zasler N; Nidiffer FD; DaVanzo J; Barth JT
    J Neurotrauma; 2008 Oct; 25(10):1135-52. PubMed ID: 18842105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotection in traumatic brain injury.
    Jain KK
    Drug Discov Today; 2008 Dec; 13(23-24):1082-9. PubMed ID: 18848641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI): a prospective longitudinal observational study.
    Maas AI; Menon DK; Steyerberg EW; Citerio G; Lecky F; Manley GT; Hill S; Legrand V; Sorgner A;
    Neurosurgery; 2015 Jan; 76(1):67-80. PubMed ID: 25525693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propranolol and Mesenchymal Stromal Cells Combine to Treat Traumatic Brain Injury.
    Kota DJ; Prabhakara KS; van Brummen AJ; Bedi S; Xue H; DiCarlo B; Cox CS; Olson SD
    Stem Cells Transl Med; 2016 Jan; 5(1):33-44. PubMed ID: 26586775
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.